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ABSTRACT
Constraint based modelling has seen applications in many microorganisms. For example,
there are now established methods to determine potential genetic modifications and external
interventions to increase the efficiency of microbial strains in chemical production pipelines. In
addition, multiple models of multicellular organisms have been created including plants and
humans. While initially the focus here was on modelling individual cell types of the multicellular
organism, this focus recently started to switch. Models of microbial communities, as well as multi-
tissue models of higher organisms have been constructed. These models thereby can include
different parts of a plant, like root, stem or different tissue types in the same organ. Such models
can elucidate details of the interplay between symbiotic organisms, as well as the concerted
efforts of multiple tissues and can be applied to analyse the effects of drugs or mutations on a
more systemic level. In this review we give an overview of the recent development of multi-tissue
models using constraint based techniques and the methods employed when investigating these
models. We further highlight advances in combining constraint based models with dynamic and
regulatory information and give an overview of these types of hybrid or multi-level approaches.
Keywords: Multi-scale modelling, constraint based modelling, multi-tissue modelling, multi-organism modelling, metabolic modelling
1 INTRODUCTION
While genome sequences are now readily available, determining the metabolic properties of organisms is
still an open problem. Numerous methods for modelling and analyzing metabolism exist (for a general
comparison please refer to (Bordbar et al., 2014)), including a large diversity of multi-scale approaches. E.g.
Karr et al. (2012) reconstructed a whole-cell model of Mycoplasma genitalium. The overall model combines
multiple different modelling techniques for describing different levels of the organism, reaching from
regulatory signaling to metabolism and other pathways. However, its comprehensiveness leads to a large
number of parameters, making this approach practically quite challenging for more complex organisms.
There also exist some applications of kinetic modelling to study different tissues, like liver (Ricken et al.,
2015; Zeigerer et al., 2015), heart (Crampin et al., 2004), and brain metabolism (Jolivet et al., 2015),
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mainly in the framework of the Virtual Physiological Human Project (Viceconti et al., 2008). A hepatocyte
model integrating signaling and regulatory information along with metabolism based on kinetic modelling
has recently been published (Ryll et al., 2014). Petri-nets form another approach used for multi-scale
modelling (Berestovsky et al., 2013). However, due to the availability of genome annotations and the lack
of knowledge on kinetic parameters, stoichiometric network models of metabolism form an widely used
and very scalable basis. The concept of constraint based modelling (CBM) allows fast calculations of large
networks under the steady state assumption, relying mainly on genetic information easily obtainable by
genome sequencing. Recent combinations of these types of models with other modelling techniques show
promising results. We will therefore focus in this review on constraint based modelling and its combination
with other techniques.
Constraint based modelling (CBM) aims at helping researchers to get a better insight into the complex
system of metabolism (Llaneras and Pico´, 2008). Additionally, they exploit the property of metabolism
that reactions have defined substrates and products. Based on a network of biochemical reactions, a
stoichiometric matrix S is created, with columns representing reactions, rows representing metabolites,
and entries S(i, j) representing the stoichiometric coefficient of metabolite i in reaction j. For larger
networks this requires the application of computational tools usually providing the models in SBML format
being an important step towards reproducible science (Pfau et al., 2015). The major constraint imposed by
CBM methods is the assumption of an internal quasi steady state of the investigated system. It is assumed
that the internal concentrations of metabolites do not change over time (i.e. S · v = 0 , where v is the
flux distribution vector of the system). In addition, three primary constraints are introduced to obtain
biologically relevant solutions (Lewis et al., 2012; Orth and Palsson, 2010): mass and charge conservation
within reactions, dependency on substrate and enzyme availability and reversibility constraints based on
thermodynamics. It is also common to employ an objective function that the system is assumed to be
optimized for (Schuetz et al., 2007). The implemented functions range from growth (Feist and Palsson,
2010) over production of ATP to complex combinations of multiple simpler objectives (Vo et al., 2004) and
are a particular challenge when multicellular organisms are the target of research. One of the most common
approaches to CBM is the use of flux balance analysis (FBA) (Savinell and Palsson, 1992; Varma and
Palsson, 1994; Kauffman et al., 2003; Raman and Chandra, 2009; Orth and Palsson, 2010). FBA has been
used to investigate the effects of knockouts on metabolism (Segre` et al., 2002; Shlomi et al., 2005) and to
design knockout strategies for metabolic engineering (Burgard et al., 2003; Rocha et al., 2010; von Kamp
and Klamt, 2014). Basic FBA however, does not account for model dynamics like gene regulation, signaling
processes, or metabolic regulation (Orth and Palsson, 2010). Therefore, approaches considering these
regulatory elements have been developed (Covert and Palsson, 2002; Mahadevan et al., 2002; Covert et al.,
2008). Models for multiple species from all biological kingdoms (prokaryotes, eukaryotes and archaea)
have been reconstructed (see http://systemsbiology.ucsd.edu/InSilicoOrganisms/OtherOrganisms), and their
number is constantly increasing. While the first models used in CBM were mostly aimed at central carbon
metabolism, the ever growing availability of genome sequences has let to a rapid increase in genome scale
metabolic reconstructions (GSM). The first GSM was Haemophilus influenzae Rd (Edwards and Palsson,
1999) in 1999, followed four years later by the first eukaryotic model (Saccharomyces cervisiae) (Fo¨rster
et al., 2003) and the first mammalian model (Mus musculus) in 2005 (Sheikh et al., 2005). The first human
reconstruction (Recon1 by Duarte et al. (2007)) was closely followed by the publication of a second
human GSM, the Edinburgh Human Metabolic Network, within the same year (Ma et al., 2007). These
initial models have seen many improved versions over the past years (e.g. Recon2 (Thiele et al., 2013)
and HMR2 (Mardinoglu et al., 2014) for human). While general reconstructions serve as an important
knowledge base for our understanding of metabolic capabilities within the reconstructed organism, they
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are limited when investigating multicellular organisms exhibiting multiple different tissues. Since different
cell types of higher organisms have different functions, and indeed different capabilities, it is therefore
necessary to reconstruct tissue specific models. In a recent review, Ryu et al. (2015) give an extensive
overview over currently available reconstructions. In addition to manual reconstruction, multiple methods
exist for contextualization of metabolic networks (reviewed in Resendis-Antonio et al. (2014), Machado
and Herrga˚rd (2014), Robaina Este´vez and Nikoloski (2014) and Ryu et al. (2015)). While tissue specificity
can help to elucidate important information about a specific tissue, a single tissue model on its own is
unable to inform about the complex interactions occurring in a higher organism. This necessitates the
combination of models presenting multiple tissues. In this review we will first provide an overview of
methods developed for the integration of non metabolic information in constraint based models and give an
overview of methods used for model simulation. We will continue by detailing the recent development
of constraint based models spanning multiple organisms or tissues along with methods employed when
investigating these models. Finally we will present recent advances in combining constraint based models
with dynamic and regulatory information and give an overview of these types of hybrid or multi-scale
approaches.
2 FBA METHOD: DATA INTEGRATION AND EXTENSIONS
Multiple methods can be used to improve constraint based model predictions. Figure 1 provides an overview
of these methods, ordered by their time of publication. These methods include ways to integrate regulatory
events which can influence the activity of reactions by altering the production of specific proteins necessary
to catalyze these reactions. They also provide concepts which allow the use of omics data to determine the
availability of enzymatic activities. The first attempts to integrate non metabolic information into a CBM
analysis was introduced by Covert et al. (2001), who linked regulatory data to a CBM model of Escherichia
coli turning reactions on and off (a method termed rFBA). The principle of flux adjustment based on
external data was picked up by others and either used to switch reactions on or off (Becker and Palsson,
2008; Vlassis et al., 2014) or to adjust the bonds of fluxes (Colijn et al., 2009; Lee et al., 2012). The former
try to derive the activity state of genes and assign reaction availabilities based on these activities using
Boolean gene-protein-reaction association rules. These rules are similar to the Boolean rules used by Covert
et al. for regulatory constraints, but only use gene activity information, where Covert et al. used additional
information, like the availability of a preferred carbon source deactivating a second importer. These
methods used for omics integration have received much attention lately and were extensively reviewed in
(Machado and Herrga˚rd, 2014) and (Robaina Este´vez and Nikoloski, 2014). The reviews focused on flux
bound adjustment and network structure contextualization, respectively.
Simultaneous to the development of rFBA, Mahadevan et al. introduced the concept of dynamic FBA
(dFBA), which allows the simulation of time courses using FBA (Mahadevan et al., 2002). The idea is
to use the resulting outputs (e.g. remaining amount of substrate, generated products) of an earlier time
step as inputs for the next time step. Both concepts where later combined to form integrated dynamic FBA
(iFBA or idFBA) which uses both time dependent regulatory information and the dFBA approach (Covert
et al., 2008; Lee et al., 2008). In addition, Covert et al. used a small dynamic ODE model to dynamically
simulate parts of the network based on the results of the earlier time step. This was also the first attempt
to combine constraint based and dynamic models in a common framework. In iFBA the ODE model was
solved to calculate initial rates, which were subsequently applied to the constraint based model as flux
bounds. In addition, gene expression data for each time step was applied to the CBM restricting the active
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parts. Finally, the CBM was optimized and the resulting metabolite concentrations used as inputs to the
next iteration of the ODE model.
Integration of different data types on the same model, requires the development of new optimization
approaches. Each of these approaches is specifically designed for the research problem of interest. In Table
1, an overview on the main FBA-based methods discussed in this review is given. For a broader view
on FBA methods, please refer to Lewis et al. (2012). Since 2012, other optimization methods have been
developed, and we will briefly present some of them here. Pozo et al. (2012) developed a new optimization
algorithm which allows to determine the global optimum of kinetic metabolic models while optimizing
for multiple-objectives. Additionally, this algorithm allows the selection of sets of the most efficient
optimal alternatives. This optimization approach can be very interesting when being applied to metabolic
engineering, i.e. it can be applied when the objective is to optimize the synthesis rate of metabolite
X, at minimum cost, and with minimum concentration change of intermediate metabolites. Recently,
another approach, developed by Andreozzi et al. (2015), employs CBMs at steady-state and metabolite
concentrations to derive feasible kinetic models which are representative of a specific physiological state.
As the previous algorithm, this framework is easily applicable to metabolic engineering and can give hints
about which enzymes to alter in order to achieve a specific physiological state. Furthermore, it can be used
to decrease the uncertainty related with kinetic parameter estimation and to efficiently sample the solution
space.
Constraint based metabolic models are commonly aimed to simulate the metabolism of small molecules
and tend to include macromolecular biosynthesis and modifications only implicitly by the inclusion of
energy or reductant consuming reactions. Recently this neglect has been addressed in studies on E.coli and
Thermotoga maritima which explicitly modelled the macromolecular biosynthesis machinery (Thiele et al.,
2012; Lerman et al., 2012). The basis for this approach is a CBM model of the target organism, which
was noted as M-matrix and a stoichiometric model of the macromolecular synthesis machinery, noted
as E-matrix. The models are combined by forming a large ME matrix and adding coupling constraints
that restrict the flux through reactions by requiring the catalyzing enzymes to be available. In addition,
biomass is adjusted to reflect the explicit costs of macromolecular synthesis and amino acids, since proteins
are allowed to accumulate in the model. In Thiele et al. (2012), the ME-model was simulated and the
predictions matched with experimental growth rates and knockout phenotypes. Lerman et al. (2012) used
the technique to investigate minimal ribosomal production rates necessary at specific growth rates, and
could show changes consistent with experimental data. They also found pathways which become necessary
for efficient growth in the ME-model but which are not important in a pure metabolic model. Thiele et al.
(2012) mention that performing FBA in the ME-matrix is time consuming, therefore this approach does
not easily scale to larger models. In practice, this dimensionality is likely to become too high for many
eukaryotic models.
To tackle more complex systems the classic FBA formulation optimizing for a single objective is often
insufficient. One approach to handle those multi-objective systems is to use a concept called pareto
optimality, where a solution is searched for which any change would lead to the worsening of at least one
objective (Oh et al., 2009). The concept has been applied to optimize a human mitochondrial model taking
into consideration three objective functions (Vo et al., 2004). There are different ways to combine objectives,
e.g. by weighted sums of objective functions, or by successive optimization and fixation of the objective
value of one target flux. However, even when multiple objectives are employed, the final solution is not
necessarily unique and the number of alternate optima might become so high that is infeasible to calculate
them. To analyze those solutions it is often useful to perform Flux Variability Analysis (FVA) (Mahadevan
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and Schilling, 2003). In contrast to FBA, FVA determines the allowed ranges of fluxes under the optimal
conditions. This can help to indicate flexible reactions, with large ranges of possible flux values, and
reactions under tight control, which show only a very small range of possible fluxes.
3 COMBINING MULTIPLE CONSTRAINT BASED MODELS
While originally flux balance analysis was used on small models, partially due to a lack of knowledge
about metabolic pathways and also due to a lack of computational resources, ever more complex models
have been constructed over the past years. These models can include multiple tissues within an organism,
or even multiple distinct organisms which interact metabolically. We will discuss the creation of these
models in the following section and provide an overview of the development of these models in Figure 2.
3.1 Constraint Based Models spanning multiple organisms
While models for isolated microbes are now quite advanced, investigations of interactions between
organisms are rare. However, there are multiple examples of interactions, either as symbiotic or mutualistic
relations (e.g. plant-mycorrhiza interactions) or as parasites (like human-pathogens). To address these
types of interactions and investigate their metabolic effects it is necessary to combine multiple organism
networks. The first attempt to perform such a combination of metabolic networks of different species
was published in 2007 by Stolyar et al. They created a combination of metabolic networks consisting of
two symbiotic microbial species and investigated the metabolic exchanges occurring between them. This
initial idea has been extended into frameworks for optimization of microbial communities (Zomorrodi and
Maranas, 2012; Zomorrodi et al., 2014). A more detailed review was published by Mahadevan and Henson
in 2012.
The concept of combining different organisms in larger models has also been used in simulating host-
pathogen interactions. Bordbar et al. (2010) developed a model of the infection of alveolar macrophages by
Myobacterium tubercolosis and successfully simulated maximal ATP and nitric oxide (NO) production
rates. For the model described by Bordbar et al. (2010), one of the most important constraints was the
level of oxygen available to the pathogen, as it is (even in simulations) unable to grow without a minimal
amount of oxygen. Furthermore the original biomass function was adjusted to the conditions in the infected
macrophage based on expression data. This was achieved in a step-wise manner. First, random sampling
was applied to determine the solution space of each individual metabolic component. Second, linear
regression was used by iteratively adding and removing metabolic components to and from the biomass
function. This process was performed until a new biomass function could better fit the gene expression
data. This led to an altered biomass definition with different metabolic components which could reflect the
infectious state of the pathogen. The resulting composition is closer to that observed in the infectious state
instead of the phase of maximal growth in vitro. The combined model with tailored objective functions was
interrogated with respect to changes in ATP, NO and NADH production fluxes in the macrophage, and in
the biomass function flux for both host and pathogen. In addition, in silico gene essentiality studies were
performed on the combined model and compared to experimental data, showing a better agreement than
the same studies on the disconnected pathogen model. Finally, flux changes in both the macrophage and
the pathogen were investigated by mapping gene expression data using the GIMME algorithm (Becker and
Palsson, 2008).
Recently, Heinken et al. (2013) focused on a model of the interactions of the microbium B. thetaiotaomi-
cron and the gut cells of a mouse model and could simulate their growth on five different dietary regimes.
The coupling between these models was achieved by creating a new compartment (the intestinal lumen)
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where the metabolites could be exchanged between the models. This multi-scale model was able to capture
the symbiotic growth between mouse and microbe and identify the metabolic crosstalk between the two
organisms.
While there have been examples of organism linkage, the main issue present in these attempts is the
determination and selection of the links between organisms. Selecting alternative linking compounds could
lead to vastly different results and while there are active transporters identified for some compounds, many
transport systems allow the exchange of multiple compounds, which makes it difficult to pin down the right
selection.
3.2 Reconstruction and analysis of multi-tissue models of higher organisms
Coupling models of different tissues within the same organism, or of specific tissues with pathogens
is conceptually similar to coupling multiple organisms. Both situations commonly define interactions by
allowing the different models to secrete and consume metabolites provided by the external medium or the
other model. The main challenges are again to find which compounds are exchanged and determine the
extent to which this exchange occurs. If the aim is to model microbial communities, there is commonly the
assumption that the aim of all community organisms is to grow. Thus any interaction between organisms
that allows a higher growth rate for both organisms is commonly beneficial for both organisms. In a
multicellular organism, with multiple distinct tissues, the aim of each tissue is commonly distinct from
growth (with the prominent exception of cancer). Thus it is important to determine the objectives or
required activities of each tissue in a multi-tissue model. Those objectives can include e.g. ammonia
detoxification in the liver or energy production in the brain. However it is also possible to define certain
functionalities that have to be provided by each tissue and assume that the general objective is to perform
these tasks most efficiently (e.g. with a minimum amount of wasted energy, or a minimal amount of
enzymes required). Thus, there are multiple challenges which have to be addressed when trying to model
multicellular organisms using multi-tissue models.
One of the earliest multi-tissue models was a two-tissue model of Arabidopsis thaliana by de Oliveira
Dal’Molin et al. (2010), describing the interactions between mesophyll and bundle-sheath cells. Other
models are often considering the different phases of day and night by creating a dual representation of
the model (Cheung et al., 2014). As these models are the result of coupling two different models (one for
the day and one for the night), they are conceptually similar to multi-scale models. In these models, the
interactions between the day and the night model are implemented as reactions which represent the storage
of compounds during either the day or the night. The concept was extended to a true multi-tissue model by
Gomes De Oliveira Dal’molin et al. (2015) who created this dual representation for roots, stem and leaves.
By investigating the exchanges the authors were able to determine the storage compounds transferred
between day and night (Cheung et al., 2014) and elucidate the effect of translocation costs between tissues
on the localization of biosynthetic activities (Gomes De Oliveira Dal’molin et al., 2015).
The recent advances in modelling multi-tissue models have also been applied to human tissues, starting
with a multi-tissue brain model by Lewis et al. (2010). They created three models for different neuron
types in the human brain: glutaminergic, γ-aminobutyrate (GABA)ergic, and cholinergic. The models
contained the following submodels: a neuron with a neuronal mitochondria, an astrocyte with an astrocytic
mitochondria, an endothelium/blood compartment and a interstitial space. The brain model used was
based on Recon1 (Duarte et al., 2007), using only reactions indicated to be localized in the brain by the
Human Protein Reference Database (Mishra et al., 2006) or by HINV (Fujii et al., 2004) and additional
reaction evidence based on literature research. The reconstructed models could then be used to investigate
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downregulated pathways in Alzheimer patients and to obtain a mechanistic overview of the effect of this
downregulation. The authors further identified potential routes of acetyl-choline precursor synthesis in the
mitochondria. The identification was performed by iteratively removing reactions from Recon1 (Duarte
et al., 2007) while retaining acetyl-CoA transport from mitochondria to the cytosol. They could determine
three main groups of potential acetyl-CoA biosynthesis using singular value decomposition on a set of
21000 unique minimal reaction sets obtained by this process. The resulting set included the major two
pathways in the generated cholinergic model and allowed the qualitative reproduction of multiple regulatory
effects on this specific neuron type.
Subsequently, Bordbar et al. (2011) established a multi-tissue model of adipocyte, hepatocyte and
myocyte. In the model by Bordbar et al. (2011), each cell model was reconstructed from Recon1 (Duarte
et al., 2007) using the SimPheny toolbox to generate initial draft models followed by manual curation. The
integration of these cell models was performed in two steps. The first step was renaming all reactions and
metabolites according to the compartments they were localized in. In addition, a new blood compartment
representing three different fluids, the interstitial fluid, the urine and the blood, was introduced. All cellular
exchange reactions were linked to this novel compartment. The second step of integration consisted of
adding a bicarbonate buffer reaction in order to achieve proton balancing in the blood compartment.
Biomass functions for each cell type were scaled to the average tissue mass and metabolite degradation
in the blood compartment was assumed to be insignificant (Bordbar et al., 2011). The analysis of this
multi-scale model was performed using FBA and FVA. When there was more than one objective function,
the FBA optimization was performed using a pareto optimality approach. The authors were able to analyze
specific interactions (like the alanine cycle and Cori cycles between liver and muscle), and could show that
those interactions are indeed necessary.
A model similar to the model constructed by Bordbar et al. has been described recently (Kumar et al.,
2014). While these two models focus on the same tissues, they differ by their method of reconstruction,
integration and analysis. Furthermore, Kumar et al. aimed at obtaining a model for diabetic mice instead of
human. However, due to the lack of a genome scale reconstruction of mice at the time, Recon1 was used
as a basis for their model. The tissue-specific reconstruction was based on the model building algorithm
(MBA) (Jerby et al., 2010). However instead of reconstructing three distinct tissue models, the overall
model was reconstructed simultaneously. To achieve this, Recon1 (Duarte et al., 2007), was triplicated
to represent all three tissues, and these “tissues” were connected. Subsequently, a high, medium and low
confidence set was defined for each part of the triplicated Recon. This extended model was then reduced to
its consistent subnetwork (i.e. to a network in which all reactions were able to carry a flux). The resulting
model was finally subjected to MBA using the defined confidence sets for the reactions in each “tissue”.
While containing the same tissues as the model by Bordbar et al., it consisted of about four times more
reactions. The authors then showed that they could transfer the model predictions on mouse phenotypes to
diabetic humans. Validation was performed by comparing model predicted phenotypes to known mouse
phenotypes based on OMIM (McKusick, 2007). Expression data was incorporated by adapting the flux
bounds according to the expression of the gene. The analysis of the physiological and diseased model was
performed with FVA using multiple steps:
1. Reactions affected by gene regulation had their flux bounds set to -100 and 100, or 0 and 100, depending
on reaction reversibility, while unaffected reaction flux bounds were equal to -1000 and 1000, or 0 and
1000, again depending on reaction reversibility;
2. An FVA of the physiological condition was calculated;
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3. The bounds for the disease states were adapted by doubling and halving the bounds for upregulated
and downregulated reactions respectively;
4. The diabetic condition was analyzed using FVA;
5. The FVA results were used to calculate the difference between the two conditions.
The resulting exchange fluxes were compared to phenotypes in the OMIM database and showed a better
agreement than the analysis on an unmodified Recon1. Finally the model was analyzed for upregulated
and downregulated metabolic pathways based on a contextualized subnetwork. This analysis was again
performed using FVA and comparing the obtained fluxes with a randomized regulation, resulting in the
indication of several tissue specific upregulated and downregulated pathways, which were in accordance
with experimental observations.
The approaches presented show that it has become feasible to simulate multi-tissue systems and that the
neglect of metabolic interactions between tissues can hide the true actions of metabolism. However, they
also indicate that it is important to define non trivial objectives for each tissue, or to analyze the qualitative
changes in flux potentials in order to obtain useful predictions. The former makes it necessary to define
the functions and their extend, which is non trivial. The latter approach might be a possibility to hint at
potential interactions/exchanges between tissues, as the automatic reconstruction will include only those
transporters strictly necessary for the functions of the network. Thus, there is much potential in multi-tissue
reconstruction that is likely to become addressed in the near future.
4 MULTI-SCALE MODELLING OF HIGHER ORGANISMS
Up to this point, we have focused mainly on purely stoichiometric models. These models have the advantage
of requiring minimal amounts of parameters needing only information about the structure of the underlying
network, while still providing the full metabolic capacity. However, they are commonly restricted to
simulate non-dynamic processes or compare the situation in two distinct conditions. We will now show
recent advances in using constraint based models as parts of larger, multi-scale, frameworks which simulate
other cellular processes using dynamic techniques.
The human liver is often a target of metabolic investigations, as it is one of the metabolically most active
tissues performing many different tasks. Thus, it comes as no surprise that the metabolic reconstruction of
hepatocytes, HepatoNet (Gille et al., 2010), is one of the most frequently employed metabolic networks
when attempts at integrating additional processes in human are performed. One of these attempts aimed at
integrating regulatory and signaling processes with metabolic networks (Fisher et al., 2013). They used a
petri net approach to model the regulatory and signaling network in a dynamic fashion. The petri net was
extended by constraint nodes which were linked to the flux bounds in the metabolic model. In addition,
objective nodes in the petri net were included, which were used to set the objective in the CBM, and to
react to changes in the respective objective values. The CBM was simulated using FBA. The approach
employs iterations of the following steps:
1. Calculate the constraint and the objective nodes;
2. Update the metabolic model according to (1);
3. Optimize the metabolic model using FBA;
4. Update the Petri net objective nodes according to the new objective.
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Using the generated framework, they investigated bile acid homeostasis, and could generate time courses
in agreement with those determined experimentally. In addition, they analyzed genotype-phenotype
relationships, from which they could identify several genes which are likely critical in keeping the bile acid
homeostasis. The investigation showed a promising way to integrate the effects of regulatory networks on
metabolism in a dynamic way. It is however restricted to parts of metabolic networks, where the controlling
regulatory network is well understood.
The pharmaceutical industry routinely uses kinetic whole-body models to determine the distribution and
effects of drugs on a whole-body scale. These physiologically based pharmacokinetic models (PBPK)
aim to describe the absorption, distribution, metabolisation and excretion of compounds. They commonly
include kinetics for blood flow, and exchange rates for organs or tissues relevant for the biological question.
Additionally, they are based on prior knowledge of anatomy, physiology as well as of compounds properties.
Furthermore, they can give rise to an understanding of the macroscale effects of a drug treatment. Thus
combining these large scale models with the cellular models above provides the potential to understand both
whole-body behavior and individual cell responses and can provide information on the potential side effects
of a treatment. This concept has been applied to human (Krauss et al., 2012) and arabidopsis (Grafahrend-
Belau et al., 2013) and we will discuss both studies in more detail. In the system developed by Krauss et al.
(2012) a liver CBM and a whole-body physiologically based pharmacokinetics (PBPK) model were coupled.
In order to study, how these compounds affect cellular metabolism, the CBM models were integrated,
replacing parts of the tissue specific functions. The model chosen to serve as a CBM was Hepatonet, which
was simulated by a static dFBA approach. Since this static method uses linear programming, it is not
computationally expensive. The models were coupled using two different approaches. Indirect coupling
was used to simulate processes that have no direct effect on the PBPK model e.g. administration of a
compound that affects metabolic enzyme activity. For these processes information from the PBPK model
was used to constrain the CBM model. For processes that have a direct influence on the dynamics of the
PBPK model, direct linkage was used. To achieve this coupling, a feedback update loop was integrated in
order to update the fluxes for the next time step in the PBPK model according to those resulting from the
simulation of the CBM model. This feedback loop consists of four steps:
1. Clearance and production rates are calculated at the whole-body level using the PBPK model;
2. The upper bounds of coupled reactions in the CBM are adjusted to the calculated values;
3. The CBM is simulated and the coupled rates are determined;
4. The directly coupled PBPK rates are set to the rates obtained in 3 to determine the metabolite levels
for the next iteration.
Indirect coupling was used to simulate both the effect of allopurinol treatment on hyperuricemia and a
paracetamol overdose causing liver toxification. Direct coupling of the models was employed to simulate
impaired ammonia detoxification, where the activity of a specific enzyme in the CBM was impaired. The
modelling approach can be applied to study different processes, inferring the effect of cellular alterations
on the whole-body level. However, it does not allow a direct assessment of the cellular flux distribution, as
the objective used in the CBM model is to maximize the coupled fluxes while minimizing the remaining
fluxes, which can lead to odd internal flux distributions.
In an approach similar to the one used by Krauss et al. (2012), Grafahrend-Belau et al. (2013) were
simulating a multi-scale model of barley. The multi-tissue plant model was reconstructed from literature-
based biochemical reactions and databases. It included leaf, stem, seed and root models which were
coupled by adding a phloem compartment that was used for the exchange of carbon and nitrogen sources
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between the different plant compartments. The multi-tissue model was coupled to the dynamic whole-plant
ProNet-CN model (Mueller et al., 2012). In order to analyze the multi-tissue model, dynamic FBA was
used. The optimization of the multi-tissue model was performed in two steps: first the carbon uptake
was minimized and the result was used to constrain the second optimization step which consisted of a
minimization of all fluxes using the minimal carbon uptake. The coupling approaches were similar to
those used by Krauss et al. (2012). The resulting modelling framework was then used to study the seed
developmental phase of barley plants.
As could be seen, there are many approaches, to add additional levels of cellular processes to constraint
based models, or use constraint based models as parts of complex whole organism simulations. And while
recently a whole-cell model of Mycoplasma genitalium has been published by Karr et al. (2012), this model
requires over 1900 parameters to be fitted or determined. While this has been achieved on a prokaryotic,
rather “simple” system, the same would require many more parameters for eukaryotic cells and likely at
least an order of magnitude more for multicellular organisms, exhibiting multiple types of tissues. Thus
approaches with simplified processes, like CBM models, will serve as a good basis for quite some time to
come, but as we showed, it is always possible to combine them with other types of models, to improve our
capabilities in simulating the effects of metabolic interventions on larger systems.
5 CONCLUSION
Even with our constantly growing understanding of the kinetic properties of enzymatic processes, the
multitude of different conditions and slight variations makes it unlikely that a multi-cellular kinetic model
comprising all known metabolic pathways will be established in the near future. Thus we need modelling
techniques that can cope with the size of a complex multi-tissue network. We have presented several
examples of purely constraint based modelling approaches that aim at providing these techniques. These
methods however, lack the capability to include effects like distribution limits, or the dynamic response to
the changes in metabolite levels generated by the CBM models. In the recent years, methods to combine
CBM models with other types of models have been proposed to address these issues. These techniques
could allow us to achieve a better understanding of the interactions between dynamic processes on the
whole-body scale, and cellular metabolic processes. They provide ways to integrate additional levels of
control influencing the behavior of the metabolic network, and could provide means to decipher the intricate
interactions of the different regulatory processes in a higher organism. Thus, further development and
improvement of these techniques is likely to be an important step in our voyage to a complete understanding
of metabolism.
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Figure 1. Timeline of the development of techniques for the integration of data and the simulation and
analysis of complex systems. Please refer to the main text for details. ([1] Savinell and Palsson (1992);
[2] Covert et al. (2001); [3] Mahadevan et al. (2002); [4] Mahadevan and Schilling (2003); [5] Covert
et al. (2008); [6] Lee et al. (2008); [7] Vo et al. (2004); [8] Krauss et al. (2012); [9] Thiele et al. (2012);
[10] Lerman et al. (2012); [11] Fisher et al. (2013)), Images for [8],[9] and [10] are derived from images
taken from the respective publications which are provided under a Creative Commons attribution license
(https://creativecommons.org/licenses/by/2.0/)
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Figure 2. Timeline of development of reconstruction of metabolic models and realisation of different
models spanning multiple tissues or organisms. Except for the development of the initial genome scale
reconstructions from various kingdoms of live, only multi-tissue or multi-compartment models are listed.
([1] Edwards and Palsson (1999); [2] Fo¨rster et al. (2003); [3] Sheikh et al. (2005); [4] Duarte et al. (2007);
[5] Ma et al. (2007); [6] Stolyar et al. (2007); [7] Bordbar et al. (2010); [8] Lewis et al. (2010); [9] Bordbar
et al. (2011); [10] Zomorrodi and Maranas (2012); [11] Heinken et al. (2013); [12] Grafahrend-Belau
et al. (2013); [13] Cheung et al. (2014); [14] Kumar et al. (2014); [15] Gomes De Oliveira Dal’molin et al.
(2015))
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